Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Somatuline Depot

(soh-MA-too-leen DEE-poh)
A drug that is similar to somatostatin (a hormone made by the body) and is used to treat certain types of gastroenteropancreatic neuroendocrine tumors, carcinoid syndrome, and acromegaly (a condition in which the pituitary gland makes too much growth hormone). Somatuline Depot may help stop the body from making extra amounts of certain hormones, including growth hormone, insulin, glucagon, and hormones that affect digestion. It may also help keep certain types of tumor cells from growing. Somatuline Depot is a type of somatostatin analog. Also called lanreotide acetate.
Search NCI's Dictionary of Cancer Terms